Study of Depressive Symptoms Predicting Postoperative Cognitive Dysfunction (DeprPOCD)

April 28, 2019 updated by: Universitätsklinikum Hamburg-Eppendorf

Are Preoperative Depressive Symptoms Predictive for Postoperative Dysfunction in Non-cardiac Surgery?

Postoperative cognitive dysfunction (POCD) describes a condition where cognitive functions such as attention, perception, concentration, learning, abstract thinking and problem solving are impaired postoperatively. These changes can be resolved after weeks and months. In some cases, changes are permanent.

Study Overview

Detailed Description

The aetiology of POCD is multifactorial. One described risk factor is preoperative existing depressive symptoms in patients undergoing cardiac surgery.

A total of 300 consecutive patients and 80 healthy controls will be enrolled in this study. Patients will be followed up at 7 days, 3 months and 1 year postoperatively. The co gnitive function will be tested and compared to tests done before surgery. Postoperatively - from the day of operation until the 7th day (except day 6) - grade of sedation, agitation, signs of delirium, pain, cardiac, respiratory, renal and infectious complications will be monitored.

Next to preoperative depressive symptoms we will also evaluate a diagnosed depression, anxiety, pain, health-related quality of life, physical comorbidities, adrenal cortical insufficiency, type of anaesthesia, intraoperative blood loss, organ complications, postoperative delirium, baseline cognitive functioning and the number of operations/anaesthetics in the study period after the initial operation as further potential predictors of POCD.

In addition, laboratory values and certain medications will be documented. These include: anaemia, hypercalcaemia, thyroidal gland hormones, electrolytes, creatinine, urea, glomerular filtration rate and cortisone therapy.

Study Type

Observational

Enrollment (Actual)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany, 20246
        • Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hamburg Eppendorf, Univ.-Prof. Dr. med. Alwin E. Goetz and Prof. Dr. med. Christian Zoellner

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Female and male patients, aged 60 years and older undergoing elective non-cardiac surgery and non-neurosurgical procedures in general anaesthesia or combined general/regional anaesthesia. To correct for practice effects and conduct additional comparisons, 80 healthy controls will be enrolled and assessed at the same time points (neuropsychological tests and questionnaires).

Description

Inclusion Criteria for patients and healthy controls:

  • Age > 60 years
  • Written informed patient's consent

Additional Inclusion Criteria for patients:

  • Elective non-cardiac surgery and non-neurosurgical procedures in general anaesthesia or combined general/regional anaesthesia
  • Minimum of duration of operation 120 minutes
  • Baseline testing 3-14 days preoperatively

Additional Inclusion Criteria for healthy controls:

  • matched for age, gender and education
  • no surgery over the study period

Exclusion Criteria for patients and healthy control:

  • German not mother tongue
  • Illiteracy
  • Mental disability
  • Vision impairment not correctable
  • Hearing impairment not correctable
  • Illegal substance abuse (current or past history)
  • Alcohol abuse (current or past history)
  • Chronic benzodiazepine use
  • Psychosis (current or past history)
  • Parkinson Disease
  • Dementia
  • Multiple sclerosis
  • Epilepsy (current or past history)
  • Cerebral tumor (current or past history)
  • Apoplexy or intracranial bleeding (current or past history)
  • Severe traumatic brain injury (current or past history)
  • Severe liver disease (Child Pugh B, C, liver insufficiency)
  • Severe kidney disease with dialysis
  • Mini Mental Status Examination < 24 points

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
elective non-cardiac surgery and non-neurosurgical procedures
300 Patients aged 60 years and older undergoing elective non-cardiac surgery and non-neurosurgical procedures in general anaesthesia or combined general/regional anaesthesia with a duration of operation of 120 minutes or longer. 80 age-, gender- and education-matched healthy controls.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of occurrence of early POCD
Time Frame: 7 days
POCD is measured by use of a neuropsychological test battery comprising the following subtests: Alertness, Go/Nogo, and Incompatibility from the TAP 2.3 (attention), Trail Making Test A and B (attention), Digit span (memory), Verbal Learning and Memory Test (memory), Regensburg Word Fluency Test (executive function)
7 days
Frequency of occurrence of intermediate POCD
Time Frame: 3 months
POCD is measured by use of a neuropsychological test battery comprising the following subtests: Alertness, Go/Nogo, and Incompatibility from the TAP 2.3 (attention), Trail Making Test A and B (attention), Digit span (memory), Verbal Learning and Memory Test (memory), Regensburg Word Fluency Test (executive function)
3 months
Frequency of occurrence of late POCD
Time Frame: 1 year
POCD is measured by use of a neuropsychological test battery comprising the following subtests: Alertness, Go/Nogo, and Incompatibility from the TAP 2.3 (attention), Trail Making Test A and B (attention), Digit span (memory), Verbal Learning and Memory Test (memory), Regensburg Word Fluency Test (executive function)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 1 year
1 year
Frequency of occurrence of postoperative delirium
Time Frame: 7th postoperative day
measured twice per day: Confusion Assessment Method (CAM-ICU) and Richmond Agitation and Sedation Scale (RASS)
7th postoperative day
Rate of organ complications (cardiac, respiratory, renal)
Time Frame: day of operation until 7th postoperative day
day of operation until 7th postoperative day
Hospital length of stay
Time Frame: day of admission until day of discharge, up to 24 weeks
day of admission until day of discharge, up to 24 weeks
Health related quality of life
Time Frame: 7 days, 3 months, 1 year after operation
Time Frame: 7 days after operation [Measure: Short Form-12 Health Survey: Item General Health] Time Frame: 3 months after operation [Measure: Short Form-12 Health Survey: Physical and mental health summary measures] Time Frame: 1 year after operation [Measure: Short Form-12 Health Survey: Physical and mental health summary measures]
7 days, 3 months, 1 year after operation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dementia
Time Frame: Change from baseline sum score on the Mini-Mental State Examination (2nd ed.) [Time Frame: Before operation to 7 days, 3 months and 1 year after operation].
Change from baseline sum score on the Mini-Mental State Examination (2nd ed.) [Time Frame: Before operation to 7 days, 3 months and 1 year after operation].
Preoperative depressive symptoms and anxiety
Time Frame: Baseline
Preoperative depressive symptoms and anxiety are assessed with the Hospital Anxiety and Depression Scale (HADS). The HADS comprises 14 Items and 2 subscales with 7 items each. The items are answered on a 4-point rating scale from 0 to 3 with a scale score varying between 0 and 21. Higher scores represent higher distress (cut-off- scores: 0-7 = normal, 8-10 = borderline, 11-14 = severe symptoms, >=15 = very severe symptoms).
Baseline
Past or present diagnosed depression
Time Frame: Baseline
A self-administered questionnaire was developed to explore pre-existing depression (current or in past medical history) and its medical or/and non-medical treatment.
Baseline
Pre- and perioperative pain
Time Frame: Baseline and interval from day of operation to day 7 after operation
Preoperative pain: Numerical Rating Scale from 0 to 10 [Time Frame: Baseline] Perioperative pain: Numerical Rating Scale from 0 to 10, averaged over one week [Time Frame: Interval from day of operation to day 7 after operation]
Baseline and interval from day of operation to day 7 after operation
Premorbid Intelligence
Time Frame: Baseline
Multiple-Choice Vocabulary Intelligence Test (MWT-B, sum score)
Baseline
Preoperative cognitive functioning
Time Frame: Baseline
Global mean z-score on the neuropsychological test battery
Baseline
Postoperative depressive symptoms and anxiety
Time Frame: 7 days, 3 months
HADS, depression scale score [Time Frame: 7 days and 3 months after operation] HADS, anxiety scale score [Time Frame: 7 days and 3 months after operation]
7 days, 3 months
Change in depressive symptoms and anxiety from baseline to 1 year
Time Frame: Change from baseline scale scores on the HADS depression and anxiety subscales [Time Frame: Before operation to 7 days, 3 months and 1 year after operation].
Change from baseline scale scores on the HADS depression and anxiety subscales [Time Frame: Before operation to 7 days, 3 months and 1 year after operation].

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julia Wiede, MD, Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hamburg Eppendorf

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

July 1, 2018

Study Completion (Actual)

October 1, 2018

Study Registration Dates

First Submitted

June 16, 2014

First Submitted That Met QC Criteria

August 4, 2014

First Posted (Estimate)

August 6, 2014

Study Record Updates

Last Update Posted (Actual)

April 30, 2019

Last Update Submitted That Met QC Criteria

April 28, 2019

Last Verified

April 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

3
Subscribe